EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus

Mohamed Lotfy, Jaipaul Singh, Huba Kalász, Kornelia Tekes, Ernest Adeghate

The Open Medicinal Chemistry Journal · 09.09.2011 · 05 (1) · 82-92

DOI: 10.2174/1874104501105010082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Medicinal Chemistry Journal, erschienen am 09.09.2011. Verfasst von Mohamed Lotfy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, UAE University. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus (DM) is a major metabolic disorder currently affecting over 200 million people worldwide. Approximately 90% of all diabetic patients suffer from Type 2 diabetes mellitus (T2DM). The world's economy coughs out billions of dollars annually to diagnose, treat and manage patients with diabetes. It has been shown that the naturally occurring gut hormones incretins, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) can preserve the morphology and function of pancreatic beta cell. In addition, GIP and GLP-1 act on insulin receptors to facilitate insulin-receptor binding, resulting in optimal glucose metabolism. This review examines the medicinal chemistry and roles of incretins, specifically, GLP-1 and drugs which can mimic its actions and prevent its enzymatic degradation. The review discussed GLP-1 agonists such as exenatide, liraglutide, taspoglutide and albiglutide. The paper also identified and reviewed a number of inhibitors, which can block dipeptidyl peptidase 4 (DPP-4), the enzyme responsible for the rapid degradation of GLP-1. These DPP-4 inhibitors include sitagliptin, saxagliptin, vildagliptin and many others which are still in the experimental phase.

Schlagwörter

Stichwörter der Autor:innen

DPP-4 inhibitorsIncretinsmedicinal chemistry.type 2 diabetes

Autor:innen und Institutionen

  • Department of Biology, Faculty of Science, UAE University.

Zitieren

APA

Lotfy, M., Singh, J., Kalász, H., Tekes, K., & Adeghate, E. (2011). Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus. The Open Medicinal Chemistry Journal, 05(1), 82-92. https://doi.org/10.2174/1874104501105010082

Vancouver

Lotfy M, Singh J, Kalász H, Tekes K, Adeghate E. Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus. The Open Medicinal Chemistry Journal. 2011;05(1):82-92. doi:10.2174/1874104501105010082

BibTeX
@article{Lotfy2011,
  author = {Lotfy, Mohamed and Singh, Jaipaul and Kalász, Huba and Tekes, Kornelia and Adeghate, Ernest},
  title = {Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus},
  journal = {The Open Medicinal Chemistry Journal},
  year = {2011},
  volume = {05},
  number = {1},
  pages = {82--92},
  doi = {10.2174/1874104501105010082}
}
Kostenlos starten →